Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Downing

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
The Lancet. Oncology|April 3, 2025
The Global Platform for Access to Childhood Cancer Medicines: addressing inequities in childhood cancer careJames R Downing, Tedros Adhanom Ghebreyesus
Hematology. American Society of Hematology. Education Program|November 25, 2006
Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemiaJames R Downing, Charles G Mullighan
Cancer Journal (Sudbury, Mass.)|October 4, 2005
Genomic assessment of pediatric acute leukemiaCharles G Mullighan, Christian Flotho, James R Downing
The New England Journal of Medicine|January 28, 2011
Genomics and the continuum of cancer careUltan McDermott, James R Downing, Michael R Stratton
The New England Journal of Medicine|April 7, 2016
Germline Mutations in Predisposition Genes in Pediatric CancerJinghui Zhang, Kim E Nichols, James R Downing
The New England Journal of Medicine|April 9, 2004
Acute lymphoblastic leukemiaChing-Hon Pui, Mary V Relling, James R Downing
The Lancet. Oncology|February 13, 2016
Redefining "rare" in paediatric cancersChing-Hon Pui, Alberto Pappo, Amar Gajjar, et al.
The Journal of Clinical Investigation|March 24, 2007
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginaseShotaro Iwamoto, Keichiro Mihara, James R Downing, et al.
Genes & Development|June 4, 2008
Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABLCharles G Mullighan, Richard T Williams, James R Downing, et al.
Lancet (London, England)|September 28, 2025
Improving survival and reducing suffering for children with NCDsJames R Downing, Tedros Adhanom Ghebreyesus, Asilbek Khudayarov, et al.
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
The Lancet. Oncology|April 3, 2025
The Global Platform for Access to Childhood Cancer Medicines: addressing inequities in childhood cancer careJames R Downing, Tedros Adhanom Ghebreyesus
Hematology. American Society of Hematology. Education Program|November 25, 2006
Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemiaJames R Downing, Charles G Mullighan
Cancer Journal (Sudbury, Mass.)|October 4, 2005
Genomic assessment of pediatric acute leukemiaCharles G Mullighan, Christian Flotho, James R Downing
The New England Journal of Medicine|January 28, 2011
Genomics and the continuum of cancer careUltan McDermott, James R Downing, Michael R Stratton
The New England Journal of Medicine|April 7, 2016
Germline Mutations in Predisposition Genes in Pediatric CancerJinghui Zhang, Kim E Nichols, James R Downing
The New England Journal of Medicine|April 9, 2004
Acute lymphoblastic leukemiaChing-Hon Pui, Mary V Relling, James R Downing
The Lancet. Oncology|February 13, 2016
Redefining "rare" in paediatric cancersChing-Hon Pui, Alberto Pappo, Amar Gajjar, et al.
The Journal of Clinical Investigation|March 24, 2007
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginaseShotaro Iwamoto, Keichiro Mihara, James R Downing, et al.
Genes & Development|June 4, 2008
Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABLCharles G Mullighan, Richard T Williams, James R Downing, et al.
Lancet (London, England)|September 28, 2025
Improving survival and reducing suffering for children with NCDsJames R Downing, Tedros Adhanom Ghebreyesus, Asilbek Khudayarov, et al.
Pageof 19